Introduction: MPA (or microscopic polyarteritis) is clinically described as patients with exclusively nongranulomatous small vessel vasculitis involving the upper or lower respiratory tract (e.g., alveolar capillaritis). The most common manifestation of MPA is
Pathologically it is a pauci-immune necrotizing vasculitis affecting small vessels, with or without involvement of medium-sized arteries [1] .
The American College of Radiology (ACR) criteria for small-vessel vasculitis include the following:
 Nasal or oral inflammation (painful or painless oral ulcers, or purulent or bloody nasal discharge).  Granulomatous inflammation on biopsy of an artery or perivascular area.
The presence of two or more of these four criteria yielded a sensitivity of 88 percent and a specificity of 92 percent. Since the ACR did not establish specific criteria for MPA, these criteria did not discriminate GPA from either MPA nor non-vasculitic diseases that can mimic GPA [2] . The most common manifestation of MPA is necrotizing glomerulonephritis and/or pulmonary capillaritis. Serologically, more than 90% of MPA patients have a positive antineutrophil cytoplasmic antibodies (ANCA) [3] . Here, we discuss a 56 year old female patient who presented with pancytopenia, and was found to have biopsy-proven small-vessel vasculitis with negative ANCA.
Case
A 65 year old woman with a past medical history of Antiphospholipid Antibody (APLA) syndrome, partial- 
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Human Immunodeficiency Virus 1/2 screening EIA Interestingly, fibrosing ILD is more commonly associated with MPO-ANCA than with other subtypes [9, 10] . This is in contrast to our patient who, being ANCA-negative, presented with ILD.
It is unclear whether fibrosing ILD significantly impacts mortality in patients with MPA [4, 10, 11] . Cloe et al, as a part of a multicentric study, followed up with 49 vasculitis patients for 15 years and reported that chronic respiratory insufficiency was significantly associated with mortality, followed by induction therapy with glucocorticoids alone and initial weight loss. There was a significant three year mortality benefit in patients treated with an immunosuppressant as induction therapy [12] . Over the course of her hospital stay, our patient was found to have pancytopenia. Pancytopenia is a rare have an increased ANA and anti-dsDNA titer with a negative ANCA. She was eventually diagnosed with lupus nephritis and ANCA-negative renal vasculitis [16] . A large multi-center study done in 1998 found that in MPA, the diagnostic sensitivity of enzyme-linked immunosorbent assay (ELISA) based tests namely anti-PR3 and anti-MPO were 26% and 58% respectively while the diagnostic sensitivity of the indirect immunofluorescence (IIF) based tests namely cANCA and pANCA were 23% and 58% respectively [17] .
However, the multi-center study also found that when the results of the IIF tests were combined with those of the ELISA tests (cANCA/anti-PR3 positive, pANCA/anti-MPO positive), the diagnostic specificity increased to 99%. It is possible that the patient might have presented with ANCA-positivity if our team had used a combination of IIF and ELISA.
Conclusion
Vasculitis associated with pancytopenia continues to be poorly understood. ANCA-negativity at the time of presentation can give a false sense of security and delay treatment. Any worsening of condition on steroids warrants the use of immunosuppressants. However, this has not been required to date and our patient remains well without evidence of progression in our two month follow-up.
